TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v 1.0-Sleep Disturbance 8a
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v 1.0-Sleep Related Impairment 8a
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: MacNew Heart Disease Health-Related Quality of Life Questionnaire (MacNew)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Q-RT-PCR for inflammation stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Q-RT-PCR for remodeling stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Pre-existing Comorbidities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of anti-DENV-3 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in synaptic density using positron emission tomography/magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Scale (24-items) Total Score Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Suppression Index after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of Implantation and Removal Procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Episodic Memory Improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bleaching Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of the neutralizing antibody to SARS-CoV-2 Delta strain and Omicron strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate of the neutralizing antibody to SARS-CoV-2 Delta strain and Omicron strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain felt by patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in minimal-erythema-dose (MED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Amount of excretion of pyrimidine-dimers (PD) in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early neurologic improvement (ENI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success rate of resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Undesirable Symptoms Tracking Form
Endpoint domain: Adverse events/effects
Primary endpoint: Static SVV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic SVV test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of POD (Postoperative Delirium)
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal functioning as measured by the Barkin Index of Maternal Functioning (BIMF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total score-change of the Perme ICU Mobility Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Corneal Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of RSV infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: NIHSS score at discharge/7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change from Baseline in Pulmonary Vascular Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Head and neck cancer symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Uptake of OFR Interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overdose
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of alterations in physiological function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of interbody fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of secondary surgical intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Adverse Product Related Events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Baseline Monthly Seizure Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adverse events (AEs) following treatment with sonelokimab in adolescents
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes in clinical laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent reduction in cellularity of breast tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Post-operative pain assessed by Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper airway collapsibility (Pcrit value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: physiological index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls Efficacy Scale- International
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Older People's Quality of Life Questionnaire (OPQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of acute graft versus host disease
Endpoint domain: Adverse events/effects
Primary endpoint: Resolution of myocardial stunning at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: App' usability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: App' acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pattern Standard Deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Test Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of iAST® compared to physicians
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical trial enrollment retention rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: dental biofilm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angle of impaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Winter Red line
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gonial index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antegonial angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Structural and functional neuroanatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurometabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Response of 20% to 100% Reduction in Weekly Parenteral Support Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rotator cuff re-tear rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mental fatigue Visual Analog Scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mental alertness Visual Analog Scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in gamma-glutamyl transferase (GGT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Confidence of blood pressure measurements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood pressure measurement knowledge quiz
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline cognitive performance score after intervention/placebo
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Discovery of predicting bio-markers for FH-deficient RCC systemic treatments response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-Second chair stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hard tissue change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-mental test score trend
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in SRH knowledge as assessed by measures of STI Knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported sexual behavior as assessed by measures of Sexual Behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality and satisfaction of healthcare experiences as assessed by measures of Health Care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants with confirmed HIV viral load >50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 12-month health resource utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients with an actionable sequencing result
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Limits of agreement between FAF and FPF areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suitability for transplantation of the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGD grade 3 at 72 hours after transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of patients with elevated IgE and/or lymphopenia with ADA metabolite test above threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prescription appropriateness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities-specific balance confidence (ABC) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients achieving complete or partial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Appeal and sensory experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in maximum keratometry (Kmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Functionality of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three years disease-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Asthma Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Albuterol Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: GCS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: General and specific quality of life in patients with head and neck cancer
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 5-Aminolevulinic Acid distribution variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Idiopathic normal pressure hydrocephalus scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline CSF volume at 2 days postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with shunt complications
Endpoint domain: Adverse events/effects
Primary endpoint: Complete cell cycle arrest (CCCA) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Locomotor capacity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural success - Number of patients with bidirectional block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in leg strength and endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline in Epigenetic Aging at 15 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Epigenetic Aging at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Epigenetic Aging at 180 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-free proportion
Endpoint domain: Mortality/survival
Primary endpoint: Somatic mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Compliance with therapeutic standards of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systolic blood pressure readings < 130 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence of antiplatelet, anticoagulant, and statin medications > 90%
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Serum level of interleukin -18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: The Modified Rankin Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Performance changes on fMRI tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fear Avoidance Belief Questionnaire (FABQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnostic accuracy of AI detection of ureteral stone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periaqueductal gray region activation - looming task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Periaqueductal gray region activation - resting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Perceived Empathic Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Social Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Percentage of Participants Experiencing Dose-Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants developing low cardiac output syndrome related poor outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AEs leading to withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: SAEs and MAAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormal laboratory tests results
Endpoint domain: Adverse events/effects
Primary endpoint: Squat Jump (SJ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVr measurement in lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve Over the Dosing Interval (AUCτ) of Tavapadon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Parent Report of Parent-child Communication Quality at Week 4
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Child Report of Parent-child Communication Quality at Week 4
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Child Substance Use Intentions at Week 4
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning